Literature DB >> 23275018

Variability and singularity arising from poor compliance in a pharmacokinetic model I: the multi-IV case.

Pierre-Emmanuel Lévy Véhel1, Jacques Lévy Véhel.   

Abstract

We consider a simple multi-IV model for drug concentration in the case of poor patient compliance. The model is a stochastic one, and is thus able to take into account an irregular drug intake schedule. Under some assumptions, we study features of the drug concentration relevant for practical purposes such as its variability or the regularity of its cumulative probability distribution. We consider five variants: random instants for drug intake with either deterministic or random doses, both in continuous and discrete-time settings, plus a model with stochastically varying elimination rate. Our computations make it possible to assess in a precise way the effect of various significant parameters such as the mean rate of intake, the elimination rate, and the mean dose. They also quantify how much poor compliance will affect the regimen: in that view, we provide precise comparisons with the variability of concentration in the cases of (a) a fully compliant patient and (b) a population of fully compliant patients with lognormally distributed elimination rates. The time discretized version of our models reveal unexpected links with measures known as infinite Bernoulli convolutions. Our findings help in understanding the consequences of poor compliance, and may have practical outcomes in terms of drug dosing and scheduling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275018     DOI: 10.1007/s10928-012-9284-y

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  5 in total

1.  Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis.

Authors:  Michael Iskedjian; Thomas R Einarson; Linda D MacKeigan; Neil Shear; Antonio Addis; Nicole Mittmann; A Lane Ilersich
Journal:  Clin Ther       Date:  2002-02       Impact factor: 3.393

2.  A pharmacokinetic formalism explicitly integrating the patient drug compliance.

Authors:  Jun Li; Fahima Nekka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-12       Impact factor: 2.745

3.  A probabilistic approach for the evaluation of pharmacological effect induced by patient irregular drug intake.

Authors:  Jun Li; Fahima Nekka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-06-25       Impact factor: 2.745

4.  A large-sample study of diazepam pharmacokinetics.

Authors:  D J Greenblatt; J S Harmatz; H Friedman; A Locniskar; R I Shader
Journal:  Ther Drug Monit       Date:  1989-11       Impact factor: 3.681

5.  A Bayesian approach for the estimation of patient compliance based on the last sampling information.

Authors:  Olivier Barrière; Jun Li; Fahima Nekka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-03-29       Impact factor: 2.745

  5 in total
  4 in total

1.  Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case.

Authors:  Lisandro J Fermín; Jacques Lévy-Véhel
Journal:  J Math Biol       Date:  2016-07-18       Impact factor: 2.259

2.  A pharmacokinetic and pharmacodynamic analysis of drug forgiveness.

Authors:  Noel P McAllister; Sean D Lawley
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-02-13       Impact factor: 2.745

3.  Variability and singularity arising from a Piecewise-Deterministic Markov Process applied to model poor patient compliance in the multi-IV case.

Authors:  Lisandro J Fermín; Jacques Lévy-Véhel
Journal:  J Appl Stat       Date:  2020-01-07       Impact factor: 1.416

4.  What should patients do if they miss a dose of medication? A theoretical approach.

Authors:  Elijah D Counterman; Sean D Lawley
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-09-10       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.